Loading Events

All Events

Discovery, Development, and Regulatory Strategy for Biologics and ADCs in Oncology and Immunology

8:00 a.m. Registration / Continental Breakfast / Vendor Exhibit
8:45 a.m. Introductory Remarks

Arian Emami Riedmaier, PhD; Chair, NJ DMDG

9:00 a.m. The Evolution of First-in-Human Dose Selection for Biologics in Oncology and Beyond

Haiqing Wang, PhD; Senior Director, DMPK, Alnylam

9:45 a.m. Mutants, Loners and Bad Influences (Systems Model of KRAS Pathway Describing Mechanism of Response in G13D CRC)

Edward Stites, MD, PhD; Associate Professor of Laboratory Medicine and Pathology, Yale School of Medicine

10:30 a.m. Vendor Exhibit & Coffee Break
11:15 a.m. Mitochondrial Bioenergetic Health Index as a Biomarker for Kidney Injury

Kiran Deshpande; PhD Candidate, Ernest Mario School of Pharmacy Rutgers, New Brunswick, NJ

11:45 p.m. Vendor Exhibit & Lunch
12:45 p.m. Immunogenicity Risk Assessments and Bioanalytical Strategy for IND Enabling Studies for Complex Biologics

Sanjay Dholakiya, PhD; Principal Scientist, BMS

1:30 p.m. Developing Effective Drug Development Strategies for Biologics

Samuel Chuang, PhD; Senior Director, Scientific Advisory Services, Charles River

2:15 p.m. Vendor Exhibit & Coffee Break
2:30 p.m. ADCs as Therapeutic Options: History, Resurgence and DXd Based ADCs from DSI

Tushar Garimella, PhD; Executive Director, Clinical Pharmacology, Daiichi-Sankyo

3:15 p.m. Medicilon Strategy & Experience for Dual Filing of ADC IND to US FDA & China NMPA

Chunlin Chen, PhD; CEO and Founder, Medicilon USA Corp.

4:00 p.m. Program close

Registration information

  • Early-bird fee (prior to March 1, 2024) is $125. Pre-registration after the early-bird date is $150. We are also offering one free attendee for every five that are pre-registered from the same companyRegistration fee at the door is $200
  • Registration fee for students and postdocs is $10 and $50 for faculty
  • Registration is free for unemployed attendees
  • If feasible, please plan to pre-register as a group, as coordinated by a member of the NJACS DMDG steering committee from your organization (see list on the following page)
  • If you have no DMDG member at your company, please contact Arian Emami Riedmaier (arian.emamiriedmaier@certara.com) or Keroles Nakhla (keroles.nakhla@novartis.com) for registration
  • Payments by personal or company checks or credit cards or registration on this site

Checks should be made payable to: NJ Drug Metabolism Discussion Group. Or please register and pay on this site.


Please contact Li Yu (liyu.pharmaconsulting@gmail.com) for information concerning exhibits

Share This Story, Choose Your Platform!

Go to Top